Production (Stage)
Sensus Healthcare, Inc.
SRTS
$4.69
$0.010.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.74% | 71.30% | 65.61% | 21.00% | -15.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.74% | 71.30% | 65.61% | 21.00% | -15.83% |
| Cost of Revenue | 38.32% | 67.97% | 55.86% | 24.78% | -7.05% |
| Gross Profit | 15.82% | 73.75% | 72.54% | 18.63% | -20.75% |
| SG&A Expenses | 34.67% | 12.63% | -19.04% | -20.79% | -17.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.89% | 36.01% | 9.86% | 0.10% | -11.57% |
| Operating Income | -53.01% | 2,206.77% | 767.47% | 277.19% | -31.67% |
| Income Before Tax | -46.36% | 1,285.87% | 1,823.03% | 206.34% | -24.88% |
| Income Tax Expenses | -7.63% | 1,330.72% | 2,289.26% | 297.24% | -21.82% |
| Earnings from Continuing Operations | -61.29% | 1,270.52% | 1,139.17% | 178.73% | -26.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.29% | 1,270.52% | 1,139.17% | 178.73% | -26.00% |
| EBIT | -53.01% | 2,206.77% | 767.47% | 277.19% | -31.67% |
| EBITDA | -50.79% | 7,741.28% | 910.81% | 241.02% | -30.82% |
| EPS Basic | -61.32% | 1,281.36% | 1,102.81% | 184.92% | -24.86% |
| Normalized Basic EPS | -46.09% | 1,389.66% | 1,638.32% | 212.19% | -24.25% |
| EPS Diluted | -63.67% | 1,493.28% | 1,026.80% | 193.37% | -23.46% |
| Normalized Diluted EPS | -46.36% | 1,386.21% | 1,568.45% | 217.66% | -23.43% |
| Average Basic Shares Outstanding | 0.32% | 0.33% | -0.01% | -0.40% | -0.85% |
| Average Diluted Shares Outstanding | 0.54% | 0.62% | -0.11% | -0.72% | -1.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |